Sanofi Contingent Value Rights
GCVRZ
GCVRZ was delisted on the 3rd of March, 2020.
118 hedge funds and large institutions have $59.7M invested in Sanofi Contingent Value Rights in 2014 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 14 increasing their positions, 21 reducing their positions, and 16 closing their positions.
5% less funds holding
Funds holding: 124 → 118 (-6)
29% less capital inflows, than outflows
Capital inflows: $3.29M | Capital outflows: $4.61M
33% less repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 21
38% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 16
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Whitebox Advisors
Minneapolis,
Minnesota
|
+$2.53M |
| 2 |
BTG Pactual Global Asset Management
Hamilton,
Bermuda
|
+$388K |
| 3 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
+$160K |
| 4 |
Allianz Asset Management
Munich,
Germany
|
+$89.1K |
| 5 |
Sphera Funds Management
Tel Aviv,
Israel
|
+$33K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MFP
Michael F. Price
|
-$1.94M |
| 2 |
SM
Scoggin Management
New York
|
-$1M |
| 3 |
Oxford Asset Management
Oxford,
United Kingdom
|
-$904K |
| 4 |
J. Goldman & Co
New York
|
-$200K |
| 5 |
GAMCO Investors
Greenwich,
Connecticut
|
-$125K |
GCVRZ Hedge Fund Activity: Q3 2014 in Review
118 of the 3,455 institutional investors tracked by Wall St. Rank reported a position in Sanofi Contingent Value Rights (GCVRZ) for Q3 2014, worth a combined $59.7M — up 3.4% from $57.7M a quarter earlier.
Sellers outnumbered buyers: 16 funds closed out of GCVRZ and 10 opened new positions — a net loss of 6 holders — while 21 trimmed existing stakes and 14 added.
The largest buyer was Whitebox Advisors, adding an estimated $2.53M. The largest seller was Michael F. Price, cutting an estimated $1.94M.
- 118 institutional investors held Sanofi Contingent Value Rights (GCVRZ) as of Q3 2014, down from 124 in Q2 2014.
- Funds reported $59.7M of Sanofi Contingent Value Rights stock for Q3 2014, up 3.4% quarter-over-quarter.
- 10 funds opened new Sanofi Contingent Value Rights positions in Q3 2014 and 16 closed out, a net change of -6 holders.
- The largest Sanofi Contingent Value Rights buyer in Q3 2014 was Whitebox Advisors, an estimated $2.53M added.
- The largest Sanofi Contingent Value Rights seller in Q3 2014 was Michael F. Price, an estimated $1.94M sold.
Based on aggregated 13F filings for Q3 2014.